Search

Your search keyword '"David-Axel Laplaud"' showing total 120 results

Search Constraints

Start Over You searched for: Author "David-Axel Laplaud" Remove constraint Author: "David-Axel Laplaud"
120 results on '"David-Axel Laplaud"'

Search Results

51. Immunologie de la sclérose en plaques

52. Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patients

53. La stratification du risque a diminué l’incidence de la LEMP chez les patients traités par natalizumab en France

54. Tolerant Kidney Transplant Patients Produce B Cells with Regulatory Properties

55. The autoimmune concept of multiple sclerosis

56. MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study

57. MSJ815602_Annex_1 – Supplemental material for Observatoire Français de la Sclérose en Plaques (OFSEP): A unique multimodal nationwide MS registry in France

58. Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data

59. SVM-based tool to detect patients with multiple sclerosis using a commercial EMG sensor

60. An intermediate level of CD161 expression defines a novel activated, inflammatory, and pathogenic subset of CD8

61. Unaltered regulatory B-cell frequency and function in patients with multiple sclerosis

62. Multiple sclerosis and pregnancy

63. Existe-t-il un biomarqueur universel sanguin de réponse aux traitements dans la sclérose en plaques ? Étude UBITMUS (Universal BIomarker of Treatment in MS)

64. Cadre nosologique et stratégie diagnostique de la myélite aiguë transverse longitudinalement étendue

65. A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort

66. Is the Choosing Wisely® campaign model applicable to the management of multiple sclerosis in France? A GRESEP pilot study

67. Recommendations for the management of multiple sclerosis relapses

68. Histoire naturelle des leucodystrophies avec mutation EIF2B : étude rétrospective multicentrique de 24 cas adultes

69. Efficacité comparée du Teriflunomide et du Dimethyl-Fumarate : une étude observationnelle française multicentrique

70. T cell recognition of self-antigen presenting cells by protein transfer assay reveals a high frequency of anti-myelin T cells in multiple sclerosis

71. Peripheral blood CD4+ T lymphocytes from multiple sclerosis patients are characterized by higher PSGL-1 expression and transmigration capacity across a human blood-brain barrier-derived endothelial cell line

72. Neuropathologic, phenotypic and functional analyses of Mucosal Associated Invariant T cells in Multiple Sclerosis

73. Blood T-cell receptor chain transcriptome in multiple sclerosis. Characterization of the T cells with altered CDR3 length distribution

74. Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine

75. αβ T-cell receptors from multiple sclerosis brain lesions show MAIT cell-related features

76. Multiple sclerosis: From new concepts to updates on management

77. Adult-onset genetic leukoencephalopathies: a MRI pattern-based approach in a comprehensive study of 154 patients

78. Targeted clinical audits immediately following the establishment of clinical practice guidelines for multiple sclerosis in 17 neurology departments: A pragmatic and collaborative study

79. Decreased Frequency of Circulating Myelin Oligodendrocyte Glycoprotein B Lymphocytes in Patients with Relapsing-Remitting Multiple Sclerosis

80. Étude rétrospective multicentrique évaluant le retentissement des traitements utilisés pour la fécondation in vitro sur le risque de poussées de Sclérose en plaques

81. Unique B cell differentiation profile in tolerant kidney transplant patients

82. Adaptative immunity and pathophysiology of multiple sclerosis

83. Mycophenolate mofetil in multiple sclerosis: a multicentre retrospective study on 344 patients

84. Régression logistique multivariée traditionnelle contre scores de propension : une étude pour mettre fin aux idées préconçues

85. No lack of regulatory B cells in patients with Multiple Sclerosis

86. Frequency of circulating autoreactive T cells committed to myelin determinants in relapsing-remitting multiple sclerosis patients

87. Recommendations for a definition of multiple sclerosis in support of early treatment

88. Recommendations for the detection and therapeutic management of cognitive impairment in multiple sclerosis

89. Recommendations for useful serum testing with suspected multiple sclerosis

91. T cell repertoire analysis and comparison between different compartments in two MS patients

92. Regulatory CD4+CD25high T cells, activated CD4+CD25highCD127high T cells and multiple sclerosis

93. Neuromyelitis optica in France: a multicenter study of 125 patients

94. Blood CD8+ T cell responses against myelin determinants in multiple sclerosis and healthy individuals

95. Patients with relapsing-remitting multiple sclerosis have normal Treg function when cells expressing IL-7 receptor alpha-chain are excluded from the analysis

96. Emotional facial palsy following striato-capsular infarction

97. [Etiology of multiple sclerosis]

98. Serial blood T cell repertoire alterations in multiple sclerosis patients; correlation with clinical and MRI parameters

99. Chitinase 3-like 1 and Chitinase 3-like 2 as Diagnostic and Prognostic Biomarkers of Multiple Sclerosis (S53.005)

100. T cell receptors of 'mucosal-associated invariant T' cells in multiple sclerosis brain lesions

Catalog

Books, media, physical & digital resources